Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068266
Filing Date
2024-08-13
Accepted
2024-08-13 16:15:30
Documents
117
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0210141-20f_chinasxt.htm   iXBRL 20-F 2142855
2 AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION, EFFECTIVE ON SEPTEM ea021014101ex1-5_chinasxt.htm EX-1.5 326343
3 CODE OF BUSINESS CONDUCT AND ETHICS ea021014101ex11_chinasxt.htm EX-11 83829
4 CERTIFICATION ea021014101ex12-1_chinasxt.htm EX-12.1 10589
5 CERTIFICATION ea021014101ex12-2_chinasxt.htm EX-12.2 10602
6 CERTIFICATION ea021014101ex13-1_chinasxt.htm EX-13.1 3943
7 CONSENT OF BEIJING W&H (TAIZHOU) LAW FIRM ea021014101ex15-1_chinasxt.htm EX-15.1 3903
8 POLICY RELATING TO RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION, AS REQUIRED BY ea021014101ex97_chinasxt.htm EX-97 39285
9 GRAPHIC image_001.jpg GRAPHIC 27133
10 GRAPHIC fin_001.jpg GRAPHIC 6415
11 GRAPHIC fin_002.jpg GRAPHIC 4624
12 GRAPHIC fin_003.jpg GRAPHIC 14312
  Complete submission text file 0001213900-24-068266.txt   9955720

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE sxtc-20240331.xsd EX-101.SCH 97058
14 XBRL CALCULATION FILE sxtc-20240331_cal.xml EX-101.CAL 69600
15 XBRL DEFINITION FILE sxtc-20240331_def.xml EX-101.DEF 412694
16 XBRL LABEL FILE sxtc-20240331_lab.xml EX-101.LAB 708134
17 XBRL PRESENTATION FILE sxtc-20240331_pre.xml EX-101.PRE 422781
120 EXTRACTED XBRL INSTANCE DOCUMENT ea0210141-20f_chinasxt_htm.xml XML 1079095
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-38773 | Film No.: 241201670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)